ETFWorld.co.uk
Image default

New iShares equity index ETF launched on Xetra

ETF offers access to biotechnology and pharmaceutical companies from the US


Sign up for our weekly Newsletter and receive the latest ETF and ETC news. Click here to register for your free copy


A new exchange traded fund issued by iShares has been tradable on Xetra and Börse Frankfurt since Thursday.

Name: iShares NASDAQ US Biotechnology UCITS ETF

Asset class: equity index ETF

ISIN: IE00BYXG2H39

Ongoing charges p.a.: 0.35 percent

Distribution policy: accumulating

Reference index: NASDAQ Biotechnology Index

The iShares NASDAQ US Biotechnology UCITS ETF enables investors to participate in the performance of biotechnology and pharmaceutical companies from the US. The index components must be listed on NASDAQ and meet set admission criteria on market capitalisation and liquidity. The maximum weighting of an index component is eight percent. In addition, a maximum of five index components are permitted to reach this limit.

Source: ETFWorld

Articoli Simili

Ossiam launches ESG Machine Learning ETF

Webmaster

New UniCredit ETF on European Green Bonds launched on Xetra

Webmaster

Two new Lyxor ETFs on Xetra

Webmaster